CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of chronic hepatitis C with PegIFN-alfa2b and ribavirin within a large German multicentric observational study: predictors of nonresponse in genotype 1 patients
DOI 10.1055/s-0029-1191935
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Hüppe, E Zehnter, S Mauss, MP Manns, G Teuber, D Tarek, S Kaiser, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, M McGlaun
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The current treatment of choice is a combination of pegylated interferon-alfa (PegIFN-alfa) plus ribavirin. Prediction of IFN efficacy before treatment has been mainly based on viral characteristics such as viral load and genotype. We therefore analyzed data from a large multicentric German surveillance study in order to identify additional host- related predictors of nonresponse. Methods: Between 9/2003 and 8…
Zitieren
Zitierempfehlung
D Hüppe, E Zehnter, S Mauss, MP Manns, G Teuber, D Tarek, S Kaiser, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, M McGlaun (2009) Treatment of chronic hepatitis C with PegIFN-alfa2b and ribavirin within a large German multicentric observational study: predictors of nonresponse in genotype 1 patients. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1191935
Mit CareLit weiterarbeiten